Results 21 to 30 of about 414,143 (313)
Antibiotics, 2022 Point-of-care diagnostic tests for community-acquired acute respiratory tract infections (CA-ARTI) can support doctors by improving antibiotic prescribing.
Sabine Vogler, Friederike Windisch
doaj +1 more source
Access to precision medicine in Thailand: a comparative study [PDF]
Journal of Health Research, 2022 Purpose – This study explored health insurance coverage of genetic testing and potential factors associated with precision medicine (PM) reimbursement in Thailand. Design/methodology/approach – The study employed a targeted review method.
Nisita Jirawutkornkul +2 more
doaj +1 more source
Towards a more transparent HTA process in Poland: new Polish HTA methodological guidelines
Journal of Market Access & Health Policy, 2017 Introduction: Health technology assessment (HTA) in Poland supports reimbursement decisions via the Polish HTA Agency (AOTMiT), whose guidelines were updated in 2016.
Krzysztof Lach +3 more
doaj +1 more source
Comparison of Cardiovascular Medicines Prices in Four European Countries
Frontiers in Public Health, 2020 The aim of the current study was to compare pricing methodologies at the manufacturer, wholesale, and retail levels, and to estimate the price differences of AT1-receptor blockers (sartans), Angiotensin-converting enzyme (ACE)—inhibitors, and their fixed-
Zornitsa Mitkova +8 more
doaj +1 more source
GMS German Medical Science, 2022 Background: Horizon scanning aims to systematically identify upcoming health technologies and thus allows policy-makers to be better prepared for the entry of new medicines with possibly high price tags into the national health system.
Vogler, Sabine
doaj +1 more source
Cost-effectiveness analysis of malaria chemoprophylaxis for travellers to West-Africa [PDF]
, 2010 Background: The importation of malaria to non-endemic countries remains a major cause of travel-related morbidity and a leading cause of travel-related hospitalizations. Currently they are three priority medications for malaria prophylaxis to West Africa:
Widmer, Lukas L +4 more
core +3 more sources
Cost Effectiveness and Resource Allocation, 2019 Background To estimate the incremental cost-effectiveness ratio (ICER) of the use of continuous subcutaneous insulin infusion (CSII) therapy versus multiple daily injections (MDI) therapy in adult patients with type 1 diabetes (T1D) at the Mexican ...
Svetlana V. Doubova +10 more
doaj +1 more source
Why licensing authorities need to consider the net value of new drugs in assigning review priorities: Addressing the tension between licensing and reimbursement [PDF]
, 2008 Pharmaceutical regulators and healthcare reimbursement authorities operate in different intellectual paradigms and adopt very different decision rules. As a result, drugs that have been licensed are often not available to all patients who could benefit ...
Angell +6 more
core +1 more source
Evidence-based health care policy in reimbursement decisions : lessons from a series of six equivocal case-studies [PDF]
, 2013 Context: Health care technological evolution through new drugs, implants and other interventions is a key driver of healthcare spending. Policy makers are currently challenged to strengthen the evidence for and cost-effectiveness of reimbursement ...
Annemans, Lieven +3 more
core +3 more sources
A comparative study of orphan drug prices in Europe
Journal of Market Access & Health Policy, 2017 Background and Objective: This study assessed price differences by comparing annual treatment costs of similarly available orphan drugs in France, Germany, Italy, Norway, Spain, Sweden, and UK.
Katherine Eve Young +3 more
doaj +1 more source